Promising results achieved with a combination of chemotherapy and two retinoids in patients with advanced non-small-cell lung cancer
- 31 March 2006
- journal article
- other
- Published by Elsevier BV in Lung Cancer
- Vol. 51 (3), 387-388
- https://doi.org/10.1016/j.lungcan.2005.11.003
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- A randomized phase III trial comparing bexarotene/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)Journal of Clinical Oncology, 2005
- A randomized phase III trial comparing bexarotene/cisplatin/vinorelbine versus cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)Journal of Clinical Oncology, 2005
- Multi-Institutional Phase I/II Trial of Oral Bexarotene in Combination With Cisplatin and Vinorelbine in Previously Untreated Patients With Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2001
- RESTORATION OF ORAL ALL-TRANS RETINOIC ACID BIOAVAILABILITY AFTER A BRIEF DRUG HOLIDAYClinical Journal of Sport Medicine, 1997